Impact of Golimumab, An Anti-Tnfα Monoclonal Antibody, On Health Related Quality of Life (Hrqol) And Work Productivity In Patients With Active Psoriatic Arthritis- 24-Week Results of The Phase Iii Go Vibrant Trial
Abstract
Authors
M Husni A Kavanaugh S Peterson C Han E Chan EC Hsia L Kim KH Lo DD Harrison N Li